Object Details
- Genentech, Inc.
- Description (Brief)
- (From insert) Herceptin is a HER2/neu receptor antagonist indicated for:
- -the threatment of HER2 overexpressing breast cancer
- -the treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma
- Location
- Currently not on view
- Credit Line
- Gift of Genentech, Inc.
- ca 2013
- product expiration date
- 2015-07
- ID Number
- 2013.0069.05
- catalog number
- 2013.0069.05
- accession number
- 2013.0069
- Object Name
- pharmaceutical
- biological
- Physical Description
- glass (overall material)
- metal (overall material)
- cardboard (overall material)
- trastuzumab, 440mg (overall ingredient)
- plastic (overall material)
- Measurements
- overall: 3 1/4 in x 2 1/8 in x 1 1/2 in; 8.255 cm x 5.3975 cm x 3.81 cm
- bottle of herceptin: 3 in x 1 5/8 in; 7.62 cm x 4.1275 cm
- bottle of bacteriostatic water for injection: 2 3/4 in x 1 3/8 in; 6.985 cm x 3.4925 cm
- overall: 4 1/2 in x 3 5/8 in x 2 3/4 in; 11.43 cm x 9.2075 cm x 6.985 cm
- place made
- United States: California, South San Francisco
- See more items in
- Medicine and Science: Medicine
- Health & Medicine
- The Antibody Initiative
- Antibody Initiative: Monoclonal Antibodies
- National Museum of American History
- Subject
- Women's Health
- Record ID
- nmah_1445156
- GUID (Link to Original Record)
- https://n2t.net/ark:/65665/ng49ca746ad-d914-704b-e053-15f76fa0b4fa
.jpg)
